caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1659572089

Taryn FortuneM.D.

NeurologyChevy Chase, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Taryn Fortune's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Aman Savani
Neurology · Carlsbad, CA
84122
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
5191
Kalpana Hari Hall
Neurology · Washington, DC
2228
SUBURBAN HOSPITAL, INC.2142
LUCY WEBB HAYES NATIONAL TRAINING SCHOOL FOR DEACONESSES & MISSIONARIE2135
BRAND, JESSE1821
Quest Diagnostics Nichols Institute, Inc.
Clinical Laboratory · Chantilly, VA
1627
SUBURBAN/NRH MEDICAL REHABILITATION INC1436
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
1421
Linda Sapin
Psychologist, Clinical · Wheaton, MD
1320
Melissa Carswell
Psychologist, Clinical · Chevy Chase, MD
1217
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,639
Unique beneficiaries
—
Total services
2,165
Distinct HCPCS
7
Medicare payment
$261K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 381 Neurology providers in MD — top quintile (cohort median 552).
QUALITY · MIPS · 2024
Final MIPS score
95.1
Quality
91.1
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.85%
Individual
PRESCRIBING · PART D · 2024
Total Rx claims
1,067
Beneficiaries
—
Total drug cost
$196K
Distinct drugs
25
Brand share
18.4%
Top prescribed drugs
Gabapentin150 claims
Donepezil Hcl142 claims
Memantine Hcl112 claims
Levetiracetam73 claims
Carbidopa/Levodopa62 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
154
By payment type
Food and Beverage$3K